Background: Hepatic hemangiomas are the most common benign hepatic tumors, and they are usually asymptomatic with normal liver function. When hepatic hemangiomas reach 4 cm, we define them as giant hemangiomas. Treatment options for giant hemangiomas are observation, surgical resection, and transcatheter arterial embolization. The aim of this study was to identify the risk factors for surgical complications.
H emangiomas are the most common benign hepatic tumor, and the prevalence ranged from 3-20% in autopsy series. (1) (2) (3) (4) The wide use of abdominal ultrasonography and computed tomography (CT) for various indications has increased the diagnostic rate of hepatic hemangiomas. The etiology of hepatic hemangiomas is not completely understood. They usually originate from the proliferation of vascular endothelial cells, and enlarge by ectasia rather than hyperplasia. They are well-circumscribed tumors with a clear fibrous sheath that separates them from the hepatic parenchyma, (5) and their blood supply originates from the hepatic artery. No malignant changes have been reported in hepatic hemangiomas in long-term follow-up. (6) Several diagnostic modalities are used for hepatic hemanangiomas. Sonography is usually used to screen liver nodules and a hepatic hemangioma presents as a well-defined, lobulated, homogenous hyperechoic mass. Sometimes there is a hypoechoic portion because of hemorrhage, fibrosis, or calcification. For treatment, multiphasic CT has been used to show peripheral nodular or globular enhancement and typical centripetally progressive enhancement. Magnetic resonance imaging is used to define the anatomical relationship of liver Glissonian pedicles and hemangiomas.
The incidence of hemangiomas is highest in the 3 rd to 5 th decades of life, and they are more common in women. (7) (8) (9) (10) The growth of hemangiomas may be related to hormone levels, and exposure to high levels of estrogen and progesterone, such as occurs with multiparity, pregnancy, and oral contraceptive use, may be the reason the condition is more common in women. However, the pathogenesis of hepatic hemangiomas is still controversial.
Hepatic hemangiomas are usually asymptomatic, patients have normal liver function, and the course is typically long and uneventful. (10) Because of the absence of symptoms, the size of hepatic hemangiomas can vary greatly when discovered. Giant hemangiomas are defined as tumors with a diameter > 4 cm, and symptoms rarely appear unless the tumor size exceeds 4 cm. (11) (12) (13) The symptoms of giant hemangiomas vary from a mild abdominal compressive sensation to hemoperitoneum due to tumor rupture. (12) Many treatment options are available for hepatic hemangiomas. Close observation should be reserved for asymptomatic tumors, and surgical resection is offered for symptom relief of complicated hemangiomas or lesions in which the diagnosis is uncertain. (7, 13, 14) When surgical intervention is required, enucleation is the preferred option for giant hepatic hemangiomas because it provides better preservation of the normal liver parenchyma compared with a lobectomy. (13) (14) (15) Since hepatic surgery is a significantly invasive procedure for a benign lesion, the surgical benefits and complications must be carefully weighed. Therefore, the purpose of this study was to identify associated risk factors for postoperative complications, classify the severity of the complications and review the approaches to their management.
METHODS
Between January 2000 and July 2010, 61 patients who underwent hepatic resection for giant hemangiomas (> 4 cm) were reviewed at Chang Gung Memorial Hospital, Linkou. Indications for hepatic resection included abdominal pain (n = 26), compression symptoms (n = 13), enlarging tumor size (n = 11), incidental findings during laparotomy (n = 1), tumor bleeding (n = 2) and uncertain diagnosis (n = 8). Data on clinical variables including sex, age, symptoms, the size, number, and location of the tumors, preoperative liver function tests, operative method, operative time, blood loss, length of hospital stay, and complications were collected for analysis. Tumors with medial or right anterior segment involvement or hilum attachment were classified as centrally located, whereas others were classified as peripherally located. The tumor was measured during pathological examination of the surgical specimen, and the largest diameter was recorded if there were multiple tumors.
The operative methods for the management of hepatic hemangiomas included enucleation and lobectomy (or resection). Enucleation was performed by dissecting the tumor from the surrounding hepatic parenchyma along the plane of the tumor capsule. Hepatic lobectomy was carried out by removing the hepatic parenchyma containing the hemangioma, and blood vessels and bile ducts were ligated and divided as necessary. Pringle's maneuver was used to reduce operative bleeding in select cases by alternating 15 minutes of ischemia with 5 minutes of reperfusion. A Jackson-Pratt drainage tube was placed to detect postoperative bile leakage or bleeding. Postoperative complications were evaluated according to the Clavien-Dindo classification of surgical complications. (16) The 95% confidence interval of the complication rate was calculated by the binominal test and the t-test was used for comparison of continuous variables. Data were expressed as mean standard deviation (SD). A value of p < 0.05 was considered to indicate statistical significance. All statistical analyses were performed using SPSS version 13.0 software (SPSS Inc., Chicago, IL, U.S.A.) or STATA 9.2 (College Station, Tx, U.S.A.).
RESULTS
Patient data are presented in Table 1 . Forty-five (73.8%) of the 61 patients, were women. The tumors were located in the left lobe in 26 patients (42.6%), right lobe in 24 patients (39.3%), and bilaterally in 11 patients (18.1%). Multiple tumors were found in 17 patients (27.9%) and the tumors were symptomatic in 36. The clinical analysis of these 61 patients showed there were no significant differences in tumor size (10 cm) and clinical symptoms (p = 0.201) between patients with and without complications. Nine out of 25 patients with tumors larger than 10 cm had symptoms (36%) whereas 16 out of 36 (44%) with smaller tumors (< 10 cm) had symptoms.
A total of 36 lobectomies and 25 enucleations were performed. Chi-square analysis showed no significant relationship between the type of surgery (enucleation or lobectomy) and the number or location of tumors. The data are shown in Table 2 and  Table 3 (p = 0.624 and 0.593, respectively).
Pringle's inflow control was applied in 31 patients (50.8%). Eight patients had complications, including bile leakage (n = 2), ileus (n = 4), gastrointestinal bleeding (n = 1), and a wound infection (n = 1). The complication rate was 13.1% (95% CI 5.8% to 24.2%), and no mortalities occurred.
The clinical and pathological data of patients with and without surgical complications were compared ( Table 1 ). The presence of surgical complications was not related to age, sex, tumor location or number. There was a trend that centrally located tumors had a higher incidence of complications, but it was not significantly different (p = 0.067). Preoperative liver function was also comparable in both groups. However, the 8 patients who experienced complications were all symptomatic, and had larger tumors than patients without complications (mean, 13.1 cm vs. 9.5 cm, respectively; p = 0.021). Patients with surgical complications also had a higher rate of lobectomies (n = 7; 87.5%), a longer operative time (349 min vs. 233 min, respectively; p = 0.001), and greater intraoperative blood loss (1718 ml vs. 442 ml, respectively; p = 0.022) than those without complications. More Pringle's inflow controls were used in the group with surgical complications. The hospital stay was also longer for patients with surgical complications (15 days vs. 10 days, respectively), but the difference was not statistically significant.
In this study, grade I complications including a wound infection and postoperative ileus were successfully managed with conservative treatment (Table 4) . Postoperative ileus was the most common complication (n = 4), but no surgical intervention was required in our series. Grade II complications, including one gastrointestinal bleeding and two minor cases of bile leakage occurred in our series, and were all managed non-surgically. Neither endoscopic treatment nor transfusion was required for the patient with gastrointestinal bleeding. Medical treatment with an intravenous proton pump inhibitor and intravenous fluid supplements were adequate for this patient. Conservative treatment with percutaneous drainage was successful in both cases of bile leakage.
One case developed obstructive jaundice after hepatectomy because of angulation and stenosis of the right intrahepatic duct. Interventional treatment finally solved this problem. One case with a grade IIIa complication was treated with endoscopic retrograde cholangiopancreatography (ERCP). Internal biliary stenting was attempted initially, but failed because of sharp angulation of the right intrahepatic duct and common bile duct (Table 4) . (16) Percutaneous transhepatic cholangiography and drainage (PTCD) was then performed. In addition to external drainage, the PTCD catheter was successfully advanced to the common bile duct, and bile could be drained into the duodenum without a stent 6 months later. Follow-up after 5 years revealed no biloma recurrence or biliary tree dilatation (Table 4) . 
DISCUSSION
Giant hemangiomas are usually asymptomatic. Surgical treatment is considered when the lesion grow or symptoms occur. Operative management for hepatic hemangiomas must carefully consider the estimated risk of surgical complications. (7) In this study, we attempted to identify potential risk factors for complications, and reviewed the management of serious complications.
Rupture of a hemangioma is a rare complication that can result in death without treatment. Transcatheter arterial embolization (TAE) is one of the treatment options; however, there are only a few case reports of successful treatment of ruptured hemangiomas with TAE. (18) In our series, only two patients received angiographic embolization. The first patient had spontaneous hemoperitonium revealed by CT scan. An angiogram showed no active bleeding and the patient was stable hemodynamically. She received a hepatic resection and no postoperative complications occurred. The second patient had a 14.5 cm hemangioma at the hepatic hilum with intratumoral bleeding and presented with obstructive jaundice. Treatment with TAE failed to stabilize the patient hemodynamically, and an extended left lobectomy was performed. Her postoperative course was complicated by a wound infection that was managed with local wound care.
Management of complications is a concern because a hemangioma is a stable condition and patients have a good quality of life. In our series, grade I and grade II complications were managed conservatively. (16) Invasive procedures including ERCP and PTCD were applied for grade III complications.
A literature review of the surgical management of hepatic hemagiomas is presented in Table 5 . Most studies report a difference in outcomes between enucleation and resection. (2, (12) (13) (14) (19) (20) (21) Our early study presented by Tsai et al showed effective indications for surgery for hemangioma. (20) Thirteen of 40 patients with residual tumor showed minimal progression. The tumors ranged from 2 to 10 cm.
In the present study we focused on large tumors because they carry high risks in operations and surgical management. The surgical methods have not differed in the past two decades, and this study showed there is no significant difference in complications. Managing complications in liver surgery is the key issue to a good clinical outcome because surgical intervention still carries some risks. In this study, the statistical power was limited because of the small sample size; therefore, a study with a larger sample size is needed to locate important factors associated with complications. Although enucleation and liver resection are both curative, enucleation offers greater preservation of normal hepatic parenchyma, less blood loss, less need for blood transfusions, fewer complications, and a shorter hospital stay. Thus enucleation is the preferred technique for suitable lesions.
In this study, the complication rates for enucleation and resection were 4.0% (1/25) and 19.4% (7/36), respectively, but the difference was not statistically significant (p = 0.125). Patients with large tumors or symptoms, indicating difficulty in surgery, should be carefully managed. Giant hemangiomas with a central location also carried higher risks of complications (p = 0.067). Delicate surgical management to prevent unnecessary bleeding and to shorten operative time is important for the surgical outcome. Surgical intervention is indicated for giant hepatic hemangiomas with symptoms or hepatic lesions with an uncertain diagnosis. Resection and enucleation were both relatively safe with an acceptable complication rate (13.1%) in our series and there was no mortality. Moreover, bile leakage and pleural effusion were the most common serious complications. The rate of bile leakage after hepatic resection has been reported to be 6-11%, and most patients recover with conservative treatment. (22, 23) Endoscopic therapy such as ERCP, with or without sphincterotomy, or biliary stenting, offers another strategy for the management of surgical complications, and yields good results. (24) While testing for bile leakage during hepatic resection has been recommended, a randomized trial suggested this procedure offers no advantages. (25) 
Conclusions
Surgical resection is the treatment option for symptom relief of complicated hemangiomas or lesions in which the diagnosis is uncertain. Both enucleation and liver resection offer curative treatment; enucleation is favored because of greater preservation of liver parenchyma and fewer complications. This study identified factors associated with surgical complications in the treatment of giant hepatic hemangiomas. Clinical features including large tumor size, symptomatic tumors, increased blood loss, and prolonged operative time, indicating higher risks, were associated with an increase in postoperative complications. When complications occurred, most could be treated conservatively. However, when grade III complications developed, remedial treatment with invasive interventions such as ERCP, spincterotomy, biliary stenting, and PTCD, were the choice of treatment. For giant hepatic hemangiomas with symptoms or hepatic lesions with an uncertain diagnosis, surgical intervention is indicated. Both resection and enucleation were relatively safe with an acceptable complication rate (13.1%) in our series there was no mortality. 
